Effects of lead exposure on the expression of amyloid β and phosphorylated tau proteins in the C57BL/6 mouse hippocampus at different life stages

Journal of Trace Elements in Medicine and Biology

Volumn 28, Issue 2, 2014, Pages 227-232

  Liu, Fangli ^a,b   Xue, Zhenfei ^a   Li, Ning ^c   Huang, Hui ^a   Ying, Yanyan ^a   Li, Jin ^a   Wang, Lin ^a   Li, Wenjie ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY   (China)

^c HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Amyloid ; Lead; Learning and memory; Neurotoxicity; Phosphorylated tau protein

Indexed keywords

AMYLOID BETA PROTEIN; LEAD; TAU PROTEIN; DRINKING WATER; GRAPHITE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COGNITIVE DEFECT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPOSURE; FEMALE; HIPPOCAMPUS; LEAD BLOOD LEVEL; LEARNING DISORDER; MALE; MEMORY DISORDER; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL LEARNING; TISSUE LEVEL; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LIFE CYCLE STAGE; MAZE TEST; MEMORY; METABOLISM; PHOSPHORYLATION; TOXICITY; WESTERN BLOTTING; ATOMIC ABSORPTION SPECTROMETRY; C57BL 6 MOUSE; FEEDING; FURNACE; LACTATION; LONG TERM EXPOSURE; MATING; MORRIS WATER MAZE TEST; MOUSE; PROTEIN PHOSPHORYLATION; PUP (RODENT); SPATIAL MEMORY; WATER CONTAMINATION;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; FEMALE; HIPPOCAMPUS; LEAD; LIFE CYCLE STAGES; MALE; MAZE LEARNING; MEMORY; MICE, INBRED C57BL; PHOSPHORYLATION; SPATIAL LEARNING; TAU PROTEINS;

MUS;

EID: 84898019925     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2014.01.002     Document Type: Article

References (37)

1. Finkelstein Y., Markowitz M.E., Rosen J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Research 1998, 27(2):168-176.
2. Li N., Yang G., Qiao M., Zhen Y., Li W. Effects of maternal lead exposure on the expression of Aβ40 in the hippocampus of the filial mice. Journal of Hygiene Research 2011, 40(6):779-781.
3. Li N., Liu F., Song L., Zhang P., Qiao M., Zhao Q., et al. The effects of early life Pb exposure on the expression of IL1-β, TNF-α and Aβ in cerebral cortex of mouse pups. Journal of Trace Elements in Medicine and Biology 2014, 28(1):100-104.
4. Chen Y., Yu D., Wei Q., Han X., Hu X., Han W., et al. Effect of lead exposure on synaptic structural plasticity in the hippocampus of postnatal Wistar rat. Journal of Hygiene Research 2012, 41(3):394-398.
5. Wang X.M., Liu W.J., Zhang R., Zhou Y.K. Effects of exposure to low-level lead on spatial learning and memory and the expression of mGluR1, NMDA receptor in different developmental stages of rats. Toxicology and Industrial Health 2012, 32(12):90-94.
6. Bilbo S.D., Rudy J.W., Watkins L.R., Maier S.F. A behavioural characterization of neonatal infection-facilitated memory impairment in adult rats. Behavioural Brain Research 2006, 169(1):39-47.
7. Schneider J.S., Lee M.H., Anderson D.W., Zuck L., Lidsky T.I. Enriched environment during development is protective against lead-induced neurotoxicity. Brain Research 2001, 896(1-2):48-55.
8. Rabinowitz M.B., Wang J.D., Soong W.T. Dentine lead and child intelligence in Taiwan. Archives of Environmental Health 1991, 46(6):351-360.
9. Naicker N., Norris S.A., Mathee A., von Schirnding Y.E., Richter L. Prenatal and adolescent blood lead levels in South Africa: child, maternal and household risk factors in the Birth to Twenty cohort. Environmental Research 2010, 110(4):355-362.
10. Basha M.R., Wei W., Bakheet S.A., Benitez N., Siddiqi H.K., Ge Y.W., et al. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. The Journal of Neuroscience 2005, 25(4):823-829.
11. Xie X., Ding G., Cui C., Chen L., Gao Y., Zhou Y., et al. The effects of low-level prenatal lead exposure on birth outcomes. Environ Pollute 2013, 175:30-34.
12. Basha M.R., Murali M., Siddiqi H.K., Ghosal K., Siddiqi O.K., Lashuel H.A., et al. Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB Journal 2005, 19(14):2083-2084.
13. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. The Journal of Neuroscience 2008, 28(1):3-9.
14. Prvulovic D., Hampel H. Amyloid beta (Abeta) and phospho-tau (P-tau) as diagnostic biomarkers in Alzheimer's disease. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 2011, 49(3):367-374.
15. Ray B., Reyes P.F., Lahiri D.K. Biochemical studies in normal pressure hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Abeta) peptide and phospho-tau. Journal of Psychiatric Research 2011, 45(4):539-547.
16. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurology 2006, 5(3):228-234.
17. Bromley-Brits K., Deng Y., Song W. Morris water maze test for learning and memory deficits in Alzheimer's disease model mice. Journal of Visualized Experiments: JoVE 2011, 29(53):2920.
18. Nunez J. Morris water maze experiment. Journal of Visualized Experiments: JoVE 2008, 24(19):897.
19. Gordan M.L., Jungwirth B., Ohl F., Kellermann K., Kochs E.F., Blobner M. Evaluation of neurobehavioral deficits following different severities of cerebral ischemia in rats: a comparison between the modified hole board test and the Morris water maze test. Behavioural Brain Research 2012, 235(1):7-20.
20. Geary M., Crowley D. The Barker hypothesis. Irish Medical Journal 1999, 92(6):390-391.
21. Wilson J. The Barker hypothesis. The Australian & New Zealand Journal of Obstetrics & Gynaecology 1999, 39(1):1-7.
22. Thomas N. Beyond the Barker hypothesis and the thrifty genotype - the womb, ethnicity, genes and the environment - recent perspectives on the evolution of diabetes and the metabolic syndrome in India. Indian Journal of Endocrinology and Metabolism 2012, 16:142-146.
23. Heidmets L.T., Zharkovsky T., Jurgenson M., Jaako-Movits K., Zharkovsky A. Early post-natal, low-level lead exposure increases the number of PSA-NCAM expressing cells in the dentate gyrus of adult rat hippocampus. Neurotoxicology 2006, 27(1):39-43.
24. Chatterjee R. Lead exposure, brain damage, and adult behaviour. Environmental Science & Technology 2008, 42(14):5036.
25. Stewart W.F., Schwartz B.S., Davatzikos C., Shen D., Liu D., Wu X., et al. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology 2006, 66(10):1476-1484.
26. Mansouri M.T., Naghizadeh B., Lopez-Larrubia P., Cauli O. Behavioral deficits induced by lead exposure are accompanied by serotonergic and cholinergic alterations in the prefrontal cortex. Neurochemistry International 2013, 62(3):232-239.
27. Vazquez A., Pena de Ortiz S. Lead (Pb(+2)) impairs long-term memory and blocks learning-induced increases in hippocampal protein kinase C activity. Toxicology and Applied Pharmacology 2004, 200(1):27-39.
28. Wang X.M., Liu W.J., Zhang R., Zhou Y.K. Effects of exposure to low-level lead on spatial learning and memory and the expression of mGluR1, NMDA receptor in different developmental stages of rats. Toxicology and Industrial Health 2013, 29(8):686-696.
29. Yang Y., Ma Y., Ni L., Zhao S., Li L., Zhang J., et al. Lead exposure through gestation-only caused long-term learning/memory deficits in young adult offspring. Experimental Neurology 2003, 184(1):489-495.
30. Sun L., Zhao Z.Y., Hu J., Zhou X.L. Potential association of lead exposure during early development of mice with alteration of hippocampus nitric oxide levels and learning memory. Biomedical and Environmental Sciences 2005, 18(6):375-378.
31. Sirijovski N., Olsson U., Lundqvist J., Al-Karadaghi S., Willows R.D., Hansson M. ATPase activity associated with the magnesium chelatase H-subunit of the chlorophyll biosynthetic pathway is an artefact. The Biochemical Journal 2006, 400(3):477-484.
32. Mazumdar M., Xia W., Hofmann O., Gregas M., Sui S.H., Hide W., et al. Prenatal lead levels, plasma amyloid beta levels, and gene expression in young adulthood. Environmental Health Perspectives 2012, 120(5):702-707.
33. Yuan L., Han W.N., Li S.F., Liu X.J., Wu M.N., Qi J.S. Gly14-human in protects against Abeta31-35 induced impairment of spatial learning and memory in rats. Acta Physiologica Sinica 2012, 64(6):625-632.
34. Desikan R.S., McEvoy L.K., Thompson W.K., Holland D., Brewer J.B., Aisen P.S., et al. Amyloid-beta-associated clinical decline occurs only in the presence of elevated P-tau. Archives of Neurology 2012, 69(6):709-713.
35. Henneman W.J., Vrenken H., Barnes J., Sluimer I.C., Verwey N.A., Blankenstein M.A., et al. Baseline CSF P-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. Neurology 2009, 73(12):935-940.
36. Huagn Y., Xu Y.M., Zhang J.W., Ren X.H., Suo A.Q. Effects of estrogen on P-Tau, ChAT and nerve growth factor protein expressions in the brain tissue of rats with Alzheimer's disease. Journal of Southern Medical University 2010, 30(10):2408-2410.
37. Ma Y.Q., Wu D.K., Liu J.K. mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease. Molecular Medicine Reports 2013, 7(2):623-627.